Scientific Programme – Day 3
Friday, 8th september 2023

08.00-08.30
STCC, Auditorium
Symposium 8: PURIGO NODULARIS & IL-31
Galderma

08.00 – 08.15
Dr Teofila Caplanusi, MD PhD (University Hospital Lausanne CHUV)

08.15 – 08.30
Prof Dagmar Simon (University Hospital Bern )

08.30-10.10
STCC, Auditorium
Clinical Cases and their pathological correlations
(Part I)
Chair: Prof Wolf-Henning Boehncke, University Hospital Geneva HUG
- Basel, USB: Riccardo Curatolo (08.30 – 08.50)
- CHUV: Laura Bruschi, Ophélie Marchal, Frédéric Minisini (08.50 -09.10)
Chair: Prof Jürg Hafner, University Hospital Zurich USZ
- St. Gall: Peter Do, Livia Kolb, Daniel Presig, Lukas Villiger (09.10 – 09.30)
- Lucern: Sanjive Rey, Clara Matcau (09.30 – 09.40)
Chair: Dr Emmanuel Laffitte, University Hospital Geneva HUG
- Bellinzona: Monica Sabau (09.40 – 09.50)
- Kispi USZ: Silvia Haueis (09.50 – 10.00)
- Aarau: Markus Streit (10.00 – 10.10)

10.10-10.30
Coffee break

10.30 – 11.40
STCC, Auditorium
Clinical Cases and their pathological correlations
(Part II)
Chair: Prof Thomas Kündig, University Hospital Zurich USZ
- USZ: Jürg Hafner, Christian Greis (10.30 – 10.50)
- HUG: Marion Deleaval, Antoine David, Federica Bertone (10.50 – 11.10)
Chair: Dr Olivier Gaide, University Hospital Lausanne CHUV
- Bern: Simone Böll, Julia Riggauer, Carole Anouk Zahn (11.10 – 11.30)
- Zurich, City Hospital: Johanna Ziegler, Severin Läuchli (11.30 – 11.40)

11.40-13.45
Lunch break

12.30 – 13.00
STCC, Auditorium
Symposium 9: Dupi or not to be – that is the new question in Prurigo Nodularis
Sanofi

Chair:
PD Dr Simon Müller (University Hospital Basel USB)

12.30 – 12.45
PD Dr Manuel Pereira (Charité Berlin)

12.45 – 13.00
Prof Thomas Kündig (University Hospital Zurich USZ)

12.30 – 13.00
STCC, 1BC
Satellite 6: Psoriasis and the heart – a dangerous liaison?
Chair: Prof Curdin Conrad (University Hospital Lausanne CHUV)
Amgen
Chair: Prof Curdin Conrad (University Hospital Lausanne CHUV)

12.30 – 13.00
Prof Wolf-Henning Boehncke (University Hospital Geneva HUG)

13.00 – 13.05
Short break

13.05 – 13.35
STCC, Auditorium
Satellite 7: Learn about Croma Pharma’s new injectable PhilArt: polynucleotides related studies and their added value in your esthetic practice
CROMA

Dr Hans-Joachim Laubach (Strasbourg, France)

13.35-13.40
Short break

13.40 – 14.10
STCC, Auditorium
Symposium 11: From symptom relief to Disease Modification: Opportunities for clinical practice
Chair: Prof Curdin Conrad (University Hospital Lausanne CHUV)
jANSSEN

13.40 – 13.55
Prof Knut Schäkel (University Hospital Heidelberg)

13.55 – 14.10
Prof Nikhil Yawalkar (University Hospital Bern)

13.40 – 14.10
STCC, 1BC
Satellite 8: Mogamulizumab, a targeted weapon in the therapeutic arsenal against certain cutaneous T-cell lymphomas
Kyowa Kirin

13.40 – 13.55
Cutaneous T-cell lymphoma: the role of Mogamulizumab in the therapeutic strategy
Dr Maël Blanchard (University Hospital Lausanne CHUV)

13.55 – 14.10
Mogamulizumab-associated rash: pathophysiology, diagnosis, and management
Prof. Maxime Battistella (Hospital Paris Cité)

14.10-14.20
Short break

14.20 – 14.45 / Plenary Talk
STCC, Auditorium
What's new 4: Optimising treatment choices in psoriasis
Prof Jo Lambert (Ghent University)
Chair: Prof Alexander Navarini, University Hospital Basel USB

14.45 – 15.10 / Plenary Talk
STCC, Auditorium
Unusual hamartomas of the skin in children
Prof Antonio Torrelo (Madrid, Spain)
Chair: Dr Marie-Anne Morren, University Hospital Lausanne CHUV

15.10 – 15.25
Coffee break

15.25 – 15.50 / Plenary Talk
STCC, Auditorium
Smart medicine lecture: To Mohs or not to Mohs
Prof Jürg Hafner (University Hospital Zurich USZ)
Chair: Prof Antonio Cozzio, Cantonal Hospital St. Gallen KSSG

15.50 – 16.15 / Plenary Talk
STCC, Auditorium
State of the art 3: Diagnostic workup for sclerotic skin diseases
Prof Pia Moinzadeh (University Hospital Cologne)
Chair: Dr Julie Di Lucca, Practice Dermatology Montreux

16.15 – 17.15
STCC, Auditorium
The SSDV commission for professional policy answers your questions
SSDV-Committee for Political Strategy and Communication

17.15 – 17.30
SwissTech Convention Center, Auditorium
Closing statement
Michel Gilliet and Curdin Conrad (University Hospital Lausanne CHUV)